Spread the love

OTTAWA—Canada is buying up to 1.5 million courses of oral antiviral treatments for COVID-19 in anticipation of them being approved by Health Canada. The government has signed up for an initial one million courses of antiviral treatment from Pfizer, once Health Canada endorses their safety and efficacy.The company submitted a request for approval to the federal drug regulator earlier this week. Canada has also purchased 500,000 courses of Merck’s oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug. “Access to effective, easy-to-use treatments is critical to reducing the severity of COVID infections and will help save lives,” Procurement Minister Filomena Tassi said Friday. A stock of antiviral medications will complement vaccines in fighting the pandemic, she said. “It’s just another tool in the tool box, but an important one,” she said. Some experts have hailed antiviral drugs as a game-changer in …